Abbonarsi

A guide for assessing the clinical relevance of findings in small bowel capsule endoscopy: analysis of 8064 answers of international experts to an illustrated script questionnaire - 11/11/21

Doi : 10.1016/j.clinre.2021.101637 
R. Leenhardt a, A. Koulaouzidis b, D. McNamara c, M. Keuchel d, R. Sidhu e, M.E. McAlindon e, J.C. Saurin f, R. Eliakim g, I. Fernandez-Urien Sainz h, J.N. Plevris b, G. Rahmi i, E. Rondonotti j, B. Rosa k, C. Spada l, m, E. Toth n, C. Houdeville a, C. Li a, o, M. Robaszkiewicz p, P. Marteau a, X. Dray a,
a Sorbonne Université, Endoscopy Unit, Hôpital Saint-Antoine, APHP, Paris, France 
b The Royal Infirmary of Edinburgh, Centre For Liver & Digestive Disorders, Edinburgh, United Kingdom 
c TAGG Research Centre, Department of Clinical Medicine Tallaght Hospital, Trinity College Dublin, Ireland 
d Bethesda Krankenhaus Bergedorf, Klinik für Innere Medizin, Hamburg, Germany 
e Dept. of Gastroenterology, Royal Hallamshire Hospital, Sheffield, United Kingdom 
f Gastroenterology and Endoscopy Unit, Edouard Herriot Hospital, Lyon, France 
g Dept. of Gastroenterology, Sheba Medical Center, Ramat Gan, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel 
h Hospital de Navarra, Gastroenterology, Pamplona, Spain 
i Université de Paris, Department of Gastroenterology and Digestive Endoscopy, Georges-Pompidou European Hospital, Paris, France 
j Gastroenterology Unit, Valduce Hospital, Como, Italy 
k Universidade do Minho, Hospital Senhora da Oliveira, Departamento de Gastroenterologia, Guimarães, Portugal 
l Digestive Endoscopy Unit and Gastroenterology, Fondazione Poliambulanza, Brescia, Italy 
m Digestive Endoscopy Unit, Universita Cattolica del Sacro Cuore, Roma, Italy 
n Department of Gastroenterology, Skåne University Hospital, Lund University, Malmö, Sweden 
o Drexel University, College of Arts & Sciences, Philadelphia, USA 
p La Cavale Blanche University Hospital, Endoscopy Unit, Brest, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

pagine 10
Iconografia 2
Video 0
Altro 0

Highlights

Small bowel capsule endoscopy findings car be categorize as of low (P0) / intermediate (P1) / high (P2) relevance, but this classification is currently based on a low level of knowledge.
The answers of 14 small bowel capsule endoscopy European experts to a 576-question illustrated script questionnaire establishe a guide for the evaluation of relevance of SBCE findings.
Red spots/dots, erythematous patch, phlebectasia, lymphangiectasia and chylous cysts are of low clinical relevance (P0), and may be considered as normal variants in most cases.
In overt or occult OGIB, resultant P2 findings were ‘typical angiectasia’, ‘deep ulceration’, ‘stenosis’, and ‘blood’, whatever their numbers, and ‘superficial ulcerations’ when multiple.
In suspected CD, consensus P2 lesions were ‘deep ulceration’ and ‘stenosis’ whatever their numbers, and ‘aphthoid erosions’ and ‘superficial ulcerations’ when multiple.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background and aim

Although recommended, the P-score used for assessing the pertinence / relevance of findings seen in small bowel (SB) capsule endoscopy (CE) is based on a low level of knowledge. The aim of this study was to evaluate the clinical relevance of the most frequent SBCE findings through an illustrated script questionnaire.

Materials and Methods

Sixteen types of SBCE findings were illustrated four times each in three different settings (occult and overt obscure gastrointestinal bleeding and suspected Crohn's disease), and with a variable number (n = 1/n = 2–5/n ≥ 6), thus providing a questionnaire with 192 scenarios and 576 illustrated questions. Fifteen international experts were asked to rate the finding's relevance for each question as very unlikely (−2) / unlikely (−1) / doubtful (0) / likely (+1) / very likely (+2). The median score (≤−0.75, between -0.75 and 0.75, or ≥0.75) obtained for each scenario determined a low (P0), intermediate (P1) or high (P2) relevance, respectively.

Results

8064 answers were analyzed. Participation and completion rates were 93% and 100%, respectively. In overt or occult OGIB, resultant P2 findings were 'typical angiectasia', 'deep ulceration', 'stenosis', and'blood', whatever their numbers, and 'superficial ulcerations' when multiple. While in suspected CD, consensus P2 lesions were 'deep ulceration' and 'stenosis' whatever their numbers, and 'aphthoid erosions' and 'superficial ulcerations' when multiple.

Conclusion

This study establishes a guide for the evaluation of relevance of SBCE findings. It represents a step forward for SB-CE interpretation and is intended to be used as a tool for teaching and academic research.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Capsule endoscopy, Inflammatory bowel disease, Small bowel bleeding, Small bowel endoscopy


Mappa


© 2021  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 45 - N° 6

Articolo 101637- Novembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Trimetazidine alone or in combination with gemcitabine and/or abraxane decreased cell viability, migration and ATP levels and induced apoptosis of human pancreatic cells
  • Zülal Atlı Şekeroğlu, Vedat Şekeroğlu, Sevil Işık, Birsen Aydın
| Articolo seguente Articolo seguente
  • Surgical rather than endoscopic resection of early-stage colorectal cancers promotes excessive imaging surveillance
  • Martin Bordet, Jean-François Bretagne, Christine Piette, Chloé Rousseau, Thomas Grainville, Mathilde Cosson, Astrid Lièvre

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.